All Stories

  1. Epiproteomic profiling identifies histone H4 hyperacetylation as a prognostic marker in pleural mesothelioma
  2. Robotic Thoracic Surgery After Neoadjuvant Chemo-Immunotherapy for NSCLC: A Narrative Review
  3. European Cancer Prevention Organization on cancer screening: an expert panel position paper
  4. From cytology to systems pathology: Decoding the molecular heterogeneity of resectable non-small-cell lung cancer
  5. Methodological and inferential limits before abandoning follow‐up in node‐negative typical lung carcinoids
  6. The NET Score: An Interpretable AI-Assisted Prognostic Score for Mortality Risk in Lung Neuroendocrine Tumors
  7. Concordance of Actionable Driver Alterations Between Primary Lung Adenocarcinoma and Paired Thoracic Metastases: A Prospective Next-Generation Sequencing Study
  8. Safety and Efficacy of Single-Stage Synchronous Bilateral VATS Talc Poudrage for Malignant Pleural Effusion
  9. Correction: Prisciandaro et al. Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis. Cancers 2026, 18, 1037
  10. ERS/ESGE/ESTS clinical practice guidelines on endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer
  11. Predicting Diagnostic Success and Procedural Efficiency in Robotic Bronchoscopy Using Machine Learning
  12. Beyond survival: Pain as the main determinant of long-term quality of life after thoracic trauma surgery
  13. Oncological outcomes and prognostic factors of pulmonary metastasectomy in pancreatic cancer
  14. Is Video-Assisted Thoracoscopic Surgery Still Ethically Defensible in the Era of Robotic-Assisted Thoracic Surgery?
  15. Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis
  16. Novel Application of STRATOS for Restoration of Clavicular Stability After Oncologic Sternoclavicular Joint Resection: A Case Report and Review of the Literature
  17. Tumor biology versus nodal stage in predicting survival after resection of pulmonary atypical carcinoids
  18. 30-day postoperative mortality and the effects of hospital preparedness during the COVID-19 pandemic: a pooled analysis of prospective international cohort studies
  19. One needle, two diagnoses: a dual finding of adenocarcinoma and granulomatous reaction after EBUS-TBNA in lung cancer staging – a case report
  20. From Scalpel to Algorithms in Lung Cancer Management: Precision Requires Wisdom—Beware Not Artificial Intelligence, but Natural Stupidity
  21. Correction: Casiraghi et al. The Role of Incentive Respiratory Techniques in Enhanced Recovery After Lung Cancer Resection: A Propensity Score-Matched Study. J. Clin. Med. 2025, 14, 100
  22. The Immune Cost of the Thymus: Navigating Autoimmunity and Tumor Management in Thymic Epithelial Tumors
  23. Predictors of Loco-Regional Recurrence After Pulmonary Non-Anatomical Metastasectomy: A Multicentre Retrospective Analysis
  24. Recurrent Malignant Pericardial Effusion Management: The Pericardio-Peritoneal Window
  25. Recommendations for the standardization and management of prolonged air leaks in lung surgery
  26. Artificial intelligence in NSCLC management for revolutionizing diagnosis, prognosis, and treatment optimization: A systematic review
  27. Characterizing the Learning Curve of ION Robotic Bronchoscopy
  28. Fast Track Pathway for Lung Cancer: The Integration of ION Robotic-Assisted Bronchoscopy With Robotic Thoracic Surgical Resection
  29. Utility of Three-dimensional Holographic workstation for preoperative simulation of complex congenital heart surgery
  30. From nonintubation to tubeless: redefining perioperative strategies in modern anesthesiology and thoracic surgery
  31. Letter Re: TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma: signal or noise?
  32. Diaphragmatic plication for diaphragmatic paralysis: A systematic review and meta-analysis of surgical outcomes
  33. Neoadjuvant Chemoimmunotherapy in Stage III Non–Small Cell Lung Cancer
  34. 239P Dual AI models for perioperative decision support in resectable NSCLC: A real-world cohort analysis
  35. 163eP AI-enhanced prediction of diagnostic failure in early-stage lung cancer: Preprocedural score for ION robotic bronchoscopy
  36. The Price of Consensus: Reviewer disagreement, Editorial Dynamics, and Impact in Thoracic Oncology Publishing
  37. Survival outcomes and prognostic factors in surgically resected lung carcinoids: A 25-year retrospective analysis
  38. Biological staging in early-stage non-small-cell lung cancer: molecular risk-guided adjuvant therapy
  39. Clinicopathological Features and Prognosis of Lung Adenocarcinoma Presenting as Ground-Glass Opacity: A Single-Center Experience
  40. Broadening the evidence base for same-day discharge after video-assisted thoracoscopic surgery lung resection: Methodological considerations from the VALUE trial
  41. Correction: Robotic thymectomy for large thymomas: a multicenter study
  42. Pleurectomy/Decortication Versus Extrapleural Pneumonectomy in Pleural Mesothelioma: A Systematic Review and Meta-Analysis of Survival, Mortality, and Surgical Trends
  43. 10-Year Long-Term Outcomes of Robotic-Assisted Segmentectomy for Early-Stage Non-Small-Cell Lung Cancer
  44. Small Nodules and Big Questions: A Closer Look at the RELIANT Trial
  45. Sex Differences in Health-Related Quality of Life Following Pulmonary Resection: A Systematic Review
  46. 10-Year Long-Term Outcomes of Robotic-Assisted Segmentectomy for Early-Stage Non-Small-Cell Lung Cancer
  47. Impact of Surgical extent on survival in pulmonary typical carcinoids: a retrospective analysis
  48. Robotic thymectomy for large thymomas: a multicenter study
  49. “Vetus Sed Utilis”: Open Window Thoracostomy after Lung Surgery
  50. Reflections on the ThoRN Consensus: Toward a Multidisciplinary Integration
  51. Research progress on lung cancer complicated with pulmonary tuberculosis: a narrative review
  52. Surgical Outcomes After Neoadjuvant Chemo-Immunotherapy for Stage III NSCLC: A Systematic Review and Meta-Analysis
  53. The Short-Term Impact of Neoadjuvant Chemotherapy on the Outcome of Patients Undergoing Pneumonectomy for Lung Cancer: Is It Acceptable Nowadays?
  54. Identification and validation of diagnostic alternative splicing events in tumor-educated platelets for non-small cell lung cancer in patients with ground-glass opacity: a multicenter study
  55. Multidisciplinary international expert consensus on perioperative airway management
  56. Redefining resectability: Bridging perspectives in stage III NSCLC management
  57. The Actual Role of CPET in Predicting Postoperative Morbidity and Mortality of Patients Undergoing Pneumonectomy
  58. Unmasking the mimic: lipoid pneumonia imitating primary lung cancer - a case report series of a diagnostic challenge
  59. Unlocking the depths: the evolution of robotic-assisted bronchoscopy
  60. Surgeon preferences for self-treatment in locally advanced non–small cell lung cancer: Would we practice what we preach?
  61. Diverging trends in lung cancer: a 26-year analysis of sex-specific patterns and histological shifts in Northern Italy
  62. Raising the bar: evaluating quality and consistency in clinical guidelines for surgical management of pulmonary carcinoid
  63. The impact of SMARCA4 loss in non-small cell lung cancer therapy
  64. Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: A European Multicentre Propensity Score-Matched Analysis
  65. T4-non-small cell lung cancer invading the thoracic aorta: the role of the hybrid operating room
  66. Lobectomy or Sublobar Resection? Evidence-Based and AI-Enhanced Strategies for Early-Stage Non-Small Cell Lung Cancer
  67. Immune Escape Mechanisms in Non-Small Cell Lung Cancer: From Biological Complexity to Actionable Targets
  68. The Role of Incentive Spirometry in Enhanced Recovery After Lung Cancer Resection: A Propensity Score-Matched Study
  69. Development of an AI model for predicting hypoxia status and prognosis in non-small cell lung cancer using multi-modal data
  70. Physics at the Cutting Edge: The Essential Science Behind Thoracic Surgery
  71. Predictive and prognostic factors in patients with anaplastic lymphoma kinase rearranged early-stage lung adenocarcinoma
  72. Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes
  73. Correction: Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT)
  74. Correction: Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT) (Preprint)
  75. Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT)
  76. Optimal planning and management strategies for minimally invasive lung segmentectomies: an international Delphi consensus report
  77. Safety and Efficacy of Salvage Surgery after Treatment With Immune‐Checkpoint Adjuvant Inhibitors for Advanced Non‐Small Cell Lung Cancer: A Multicentric Study
  78. Harnessing artificial intelligence for breakthroughs in lung cancer management: are we ready for the future?
  79. 1000 Robotic-assisted lobectomies for primary lung cancer: 16 years single center experience
  80. Have lunar cycles and zodiac signs an impact on the mortality and morbidity of the lung cancer surgery?
  81. The Role of Adjuvant Chemotherapy in pN1 (IIB/IIIA) NSCLC Patients Who Undergo Pneumonectomy: Is It Still Justified in the Modern Era?
  82. Revamping Non-Small Cell Lung Cancer Treatments in Stages II and III: Preparing Healthcare for Cutting-Edge Immuno-Oncology Regimens
  83. Bridging the divide: addressing discrepancies between clinical guidelines, policy guidelines, and biomarker utilization
  84. A Multicenter Retrospective Case-Control Study on Simple vs Extended Sleeve Lobectomies
  85. Artificial intelligence in lung cancer
  86. Pneumonectomy for broncho-pulmonary carcinoids: a single centre analysis of surgical approaches and patient outcomes
  87. How General and Inflammatory Status Impacts on the Prognosis of Patients Affected by Lung Cancer: State of the Art
  88. Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration
  89. Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration
  90. Cardiopulmonary Resuscitation Training and Automatic External Defibrillators Deployment: Strengthening Community Response to Cardiac Arrest
  91. Mastering the maze: navigating prolonged air leak in thoracic surgery
  92. Pulmonary metastasectomy gaining ground in modern thoracic surgery
  93. Prognostic Factors and Clinical Outcomes of Surgical Treatment of Major Thoracic Trauma
  94. Comprehensive Pulmonary Rehabilitation for Patients with Malignant Pleural Mesothelioma: A Feasibility Pilot Study
  95. The Incidence of Winged Scapula after Thoracic Cancer Surgery: A Prospective Cohort Study
  96. Joint ERS/EACTS/ESTS clinical practice guidelines on adults with spontaneous pneumothorax
  97. Joint ERS/EACTS/ESTS clinical practice guidelines on adults with spontaneous pneumothorax
  98. Recent advances in lung cancer research: unravelling the future of treatment
  99. In solid tumors, neoadjuvant or adjuvant immune checkpoint blockade increases treatment-related grade 3 or 4 adverse events
  100. Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective
  101. Bronchopleural Fistula after Lobectomy for Lung Cancer: How to Manage This Life-Threatening Complication Using Both Old and Innovative Solutions
  102. A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives
  103. On the razor's edge: navigating mature experience and the challenges of aging in modern surgery
  104. Advances in lung cancer surgery: the role of segmentectomy in early–stage management
  105. Mediastinal cellulose pack mimicking lung cancer relapsing after lobectomy
  106. Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT) (Preprint)
  107. Outcomes following minimally invasive approaches vs. open extended lobectomy for non-small cell lung cancer: a propensity-matched analysis of the National Cancer Database
  108. Lung cancer in the era of COVID-19
  109. The role of the surgical volume for clinical outcomes in VATS lobectomy for lung cancer: a national large database multicenter analysis
  110. Anastomosis Complications after Bronchoplasty: Incidence, Risk Factors, and Treatment Options Reported by a Referral Cancer Center
  111. Noncontact remote sensing of abnormal blood pressure using a deep neural network: a novel approach for hypertension screening
  112. Chronos, Kairos, and the environmental control against radon
  113. Reply to Condello
  114. Differences in selected postoperative outcomes between simple and complex segmentectomies for lung cancer: A systematic review and meta-analysis
  115. A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials
  116. Correction: Prospective randomized study on the efficacy of three-dimensional reconstructions of bronchovascular structures on preoperative chest CT scan in patients who are candidates for pulmonary segmentectomy surgery: the PATCHES (Prospective rAndo...
  117. Robotic-assisted tracheal resection for adenoid cystic carcinoma with extracorporeal membrane oxygenation support
  118. Prospective randomized study on the efficacy of three-dimensional reconstructions of bronchovascular structures on preoperative chest CT scan in patients who are candidates for pulmonary segmentectomy surgery: the PATCHES (Prospective rAndomized sTudy ...
  119. Predictors, surrogate, and patient-reported outcomes in immunotherapy and salvage surgery for unresectable lung cancer: a single-center retrospective study
  120. The significance of general data protection regulation in the compliant data contribution to the European Society of Thoracic Surgeons database
  121. Real-world survival outcomes of wedge resection versus lobectomy for cT1a/b cN0 cM0 non-small cell lung cancer: a single center retrospective analysis
  122. The Debate on Surgical Volume and Perioperative Outcomes
  123. Assessment of the 90-day mortality risk score after video-assisted thoracoscopic lobectomy in the Italian VATS Group cohort
  124. Surgical Approaches to Pancoast Tumors
  125. Post-resectional bronchopleural fistula: aetiology, clinical management and future perspectives: a narrative review
  126. Diagnostic Performance and Cell Count of EBUS–TBNA Needle Gauges: A Prospective Trial
  127. Next-Generation Lung Cancer Surgery: A Brief Trip into the Future of the Research
  128. Nutritional status in patients with active pulmonary tuberculosis and new nutritional risk screening model for active tuberculosis: a national, multicenter, cross-sectional study in China
  129. The Role of Immunotherapy or Immuno-Chemotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review
  130. Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries
  131. The Role of Surgery in Primary Chest Wall Tumors: Over 20 Years’ Experience in Resection and Reconstruction
  132. Is It Time to Cross the Pillars of Evidence in Favor of Segmentectomies in Early-Stage Non-Small Cell Lung Cancer?
  133. Clinical impact of vaping on cardiopulmonary function and lung cancer development: an update
  134. Editorial: Near-infrared fluorescence guided surgery: State of the evidence from a health technology assessment perspective
  135. An evaluation of the methodological quality of published guidelines for the surgical treatment of pleural mesothelioma
  136. Commentary: The sublobar resections and the difference between a conjecture and a theorem
  137. A prognostic score from a multicentric retrospective analysis of patients affected by sarcoma with metachronous lung metastases undergoing metastasectomy
  138. A Practical Assessment of the Postoperative Management in Lung Cancer Surgery
  139. Prolonged air leak after video-assisted thoracic anatomical pulmonary resections: a clinical predicting model based on data from the Italian VATS group registry, a machine learning approach
  140. Prolonged air leak after lung surgery: prediction, prevention and management
  141. A brief appraisal on the GRADE methodology and the development of recommendations on the management of prolonged air leaks by the PALAS Study Group
  142. Should we use a biophysical approach in the classification and management of air leakage after lung resection?
  143. Artificial Neural Networks in Lung Cancer Research: A Narrative Review
  144. Surgical management of superior sulcus tumors: A twenty-year experience of an oncological high volume referral centre
  145. The Impact of Surgical Experience in VATS Lobectomy on Conversion and Patient Quality of Life: Results from a Comprehensive National Video-Assisted Thoracic Surgical Database
  146. A retrospective validation study of the STUMBL score for emergency department patients with blunt thoracic trauma
  147. Use of anticoagulation reversal therapy in the emergency department: a single-center real-life retrospective study
  148. Commentary: Brutus, Cassius, the Stars, and the Lung Cancer Screening Criteria
  149. Quantum surgery: the quantum mechanics insight beyond the uniportal video-assisted thoracic surgery (VATS) approach
  150. A Framework for the Definition and Interpretation of the Use of Surrogate Endpoints in Interventional Trials’
  151. Minimally Invasive Anatomical Segmentectomy versus Lobectomy in Stage IA Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
  152. A Multicenter Retrospective Cohort Study on Superior Vena Cava Resection in Non-Small-Cell Lung Cancer Surgery
  153. Factors Associated with Early Discharge after Thoracoscopic Lobectomy: Results from the Italian VATS Group Registry
  154. ARDS after Pneumonectomy: How to Prevent It? Development of a Nomogram to Predict the Risk of ARDS after Pneumonectomy for Lung Cancer
  155. Author Correction: AGREE-S: AGREE II extension for surgical interventions: appraisal instrument
  156. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries
  157. Surgical results of non-small cell lung cancer involving the heart and great vessels
  158. How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?
  159. Correction to: Cover always the bronchial stump! A flap could prevent catastrophic complications even in complete broncho‑pleural fistula
  160. Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical N2 non-small cell lung cancer
  161. The Interdisciplinary Management of Lung Cancer in the European Community
  162. The “Balloon-Like” Sign: Differential Diagnosis between Postoperative Air Leak and Residual Pleural Space: Radiological Findings and Clinical Implications of the Young–Laplace Equation
  163. In EBUS Signo Vinces: New Indications in Thoracic Oncology for Mediastinal Lymph Node Staging Using Endobronchial Ultrasound
  164. Impact of the extent of lung resection on postoperative outcomes of pulmonary metastasectomy for colorectal cancer metastases: an exploratory systematic review
  165. The extent of mediastinal lymph node dissection correlates with survival of small cell lung cancer patients after resection: a propensity score-matched cohort study analysis
  166. Cover always the bronchial stump! A flap could prevent catastrophic complications even in complete broncho-pleural fistula
  167. Editorial: Bench Research Behind Lung Cancer Surgery
  168. AGREE-S: AGREE II extension for surgical interventions: appraisal instrument
  169. Commentary: Nothing but a toothbrush for beginning the reduction of the postoperative costs in thoracic surgery
  170. Corrigendum to ‘128P Surgical management of lung metastases: A work-in-progress report from an international ESTS research group’ Annals of Oncology Volume 33 Supplement 2 (2022) S91-S92
  171. The COVID-19 repercussion on Google Trend data analyses
  172. AGREE‐S: AGREE II extension for surgical interventions – United European Gastroenterology and European Association for Endoscopic Surgery methodological guide
  173. Clinical characteristics, surgical treatments, prognosis, and prognostic factors of primary tracheal cancer patients: 20-year data of the National Cancer Center, China
  174. If a Single Swallow Does Not Make a Summer, 10 Patients Do Not Make an Alternative
  175. Risk models to predict outcomes following lung cancer surgery: where are we at?
  176. Climatic factors influence on emergency department visits
  177. Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative Review
  178. Pneumonectomy and broncho-pleural fistula: predicting factors and stratification of the risk
  179. A Delphi Consensus report from the "Prolonged Air Leak: A Survey" study group on prevention and management of postoperative air leaks after minimally invasive anatomical resections
  180. Long term results of surgery for NSCLC and aortic invasion. A multicenter retrospective cohort study
  181. 128P Surgical management of lung metastases: A work-in-progress report from an international ESTS research group
  182. Outcomes of patients discharged home with a chest tube after lung resection: a multicentre cohort study
  183. Lung cancer stage distribution from before COVID-19 through 18 months of the pandemic: the experience of a large-volume oncological referral centre
  184. Comment on The Unbearable Lightness of Difference Between Statistical and Clinical Significance
  185. Applications of artificial intelligence to prognostic stratification of COVID-19: a narrative review
  186. Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery
  187. Commentary: Go with the flow: The biophysical aspects of tracheal reconstructions
  188. Expert consensus on perioperative immunotherapy in non-small cell lung cancer: an editorial
  189. Commentary: We must constantly look at things in different ways
  190. Should we distinguish between intra and extrapericardial pulmonary artery involvement in NSCLC? A multicenter retrospective case-control study
  191. A proposal for a postoperative protocol for the early diagnosis of bronchopleural fistula after lung resection surgery
  192. THE COVID-19 REPERCUSSION ON TELEMEDICINE: A GOOGLE TREND DATA ANALYSIS
  193. MA01.03 PREC Multicentre Restrospective Study: A Preoperative Risk Classification for Synchronous Oligometastatic Non-Small Cell Lung Cancer
  194. A methodological quality evaluation of the published guidelines and recommendations about the lung cancer screening
  195. Mathematical Analysis of Relationships Between Airflows and Intrapleural Pressures After Video-Assisted Lobectomies>
  196. Google Trend Data Analysis of COVID-19 Repercussion on Lung Cancer Awareness in Italy
  197. Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study
  198. SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study
  199. Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis
  200. Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study
  201. Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)
  202. Safety Analysis of Salvage Surgery for Advanced Stages or Metastatic Lung Cancers
  203. Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review
  204. Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis
  205. The importance of being solid for a ground glass opacity of the lung
  206. Outcomes and Safety Analysis in Superior Vena Cava Resection for Extended Thymic Epithelial Tumors
  207. The land of the Lotus-eaters in the COVID-19 epidemic
  208. Post-operative outcomes and quality of life assessment after thoracoscopic lobectomy for Non-small-cell lung cancer in octogenarians: Analysis from a national database
  209. In early stage thymoma the tumor should be resected along with the complete thymus gland
  210. Veno-venous extra-corporeal membrane oxygenation-assisted right tracheal-sleeve pneumonectomy
  211. Work in progress report of a multicentre retrospective observational study to evaluate the association between the airflows and the intrapleural pressures digitally recorded after video-assisted lobectomy
  212. Autologous Blood Pleurodesis: What Is the Optimal Time Interval and Amount of Blood?
  213. A risk stratification scheme for synchronous oligometastatic non-small cell lung cancer developed by a multicentre analysis
  214. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
  215. Timing of surgery following SARS-CoV-2 infection
  216. Paying Another Tribute to the COVID-19 Pandemic: The Decrease of Early Lung Cancers
  217. Role of genomics and histology diagnosis in recurrent malignant pleural effusion
  218. The Weekday Effect on Morbidity of Lung Cancer Surgery: A Real-World Analysis
  219. Contrast-enhanced computed tomography prior to percutaneous transthoracic needle biopsy reduces the incidence of hemorrhage
  220. Predicting a Prolonged Air Leak After Video-Assisted Thoracic Surgery, Is It Really Possible?
  221. The role of pneumonectomy in thoracic surgery in the third millennium
  222. Anatomical segmentectomy versus pulmonary lobectomy for stage I non-small-cell lung cancer: patients selection and outcomes from the European Society of Thoracic Surgeons database analysis
  223. A methodological evaluation of the published consensus statements, recommendations and guidelines about surgical management in the course of coronavirus disease pandemic
  224. Commentary: We are in the same minimally invasive boat, and we have to row in the same direction
  225. Thoracic Surgical Oncology in Lombardy: How to Do It During COVID-19 Time?
  226. Euclidean Geometry Versus Metabolic Biochemistry in the Prognostic Evaluation of Thymic Epithelial Tumors
  227. Age and Clinical Presentation for Primary Spontaneous Pneumothorax
  228. Synchronous Robot-Assisted Pulmonary and Urologic Resections for Cancer
  229. Non-intubated thoracoscopic lobectomies for lung cancer: an exploratory systematic review and meta-analysis
  230. Safety Analysis of Superior Vena Cava Resection for Extended Thymic Epithelial Neoplasms>
  231. Preliminary Results of Extracorporeal Membrane Oxygenation Assisted Tracheal Sleeve Pneumonectomy for Cancer
  232. Opening and closing the doors of the lockdown in Italy without forgetting lung cancer patients
  233. Sialadenoma Papilliferum of the Bronchus: A Rare Tumour of Salivary Gland Origin
  234. Reorganization of thoracic surgery activity in a national high-volume comprehensive cancer centre in the Italian epicentre of coronavirus disease 2019
  235. Don’t get your wires crossed: epicardial wire-induced lung granuloma
  236. Should We Use the Olympic Spirit in the Controversy Between Surgery and Stereotactic Ablative Radiotherapy in Operable Early-Stage Non-Small Cell Lung Cancer?
  237. Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe
  238. Treatment of Chylothorax after Lung Resection: Indications, Timing, and Outcomes
  239. The synthesis of scientific shreds of evidence: a critical appraisal on systematic review and meta-analysis methodology
  240. Appropriate treatment approaches and prognosis of pleural mesothelioma
  241. The hearth of mathematical and statistical modelling during the Coronavirus pandemic
  242. Salvage pneumonectomy after definitive chemo-radiotherapy
  243. Management of medical complications after pneumonectomy
  244. Lung cancer surgery in oligometastatic patients: outcome and survival
  245. Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
  246. Diagnosis and Treatment of Early and Locally Advanced Non-Small-Cell Lung Cancer: The 2019 AIOM (Italian Association of Medical Oncology) Clinical Practice Guidelines
  247. Surgical Techniques for Chest Wall Diseases
  248. Approaches and Surgical Techniques for Chest Wall Trauma
  249. Minimally Invasive Pulmonary Resections Techniques—Nonanatomical Pulmonary Resections
  250. Epidemiology and management of primary spontaneous pneumothorax: a systematic review
  251. International expert consensus on the management of bleeding during VATS lung surgery
  252. International Delphi survey of the ESTS/AATS/ISTH task force on venous thromboembolism prophylaxis in thoracic surgery: the role of extended post-discharge prophylaxis
  253. Immunotherapy in the neoadjuvant settings: a new challenge for the thoracic surgeon?
  254. Commentary: The power (under control) of meta-analysis in the synthesis of clinical knowledge
  255. Health-related quality of life in lung cancer patients: validation of a national version of EORTC QLQ-LC29 questionnaire
  256. Starting a uniportal VATS program - The Bonn experience
  257. Devising the guidelines: the techniques of uniportal video-assisted thoracic surgery—postoperative management and enhanced recovery after surgery
  258. Methodology and timing of standardization
  259. The radical approach to the oligometastatic not small cell lung cancer patient: which? how? when? where?
  260. What is the European Society of Thoracic Surgeons (ESTS) Uniportal VATS Interest Group (UVIG)?
  261. Corrigendum to ‘Uniportal video-assisted thoracic surgery lobectomy: a consensus report from the Uniportal VATS Interest Group (UVIG) of the European Society of Thoracic Surgeons (ESTS)’  [Eur J Cardiothorac Surg 2019;56:224–9]
  262. Corrigendum to ‘What counts more: the patient, the surgical technique, or the hospital? A multivariable analysis of factors affecting perioperative complications of pulmonary lobectomy by video-assisted thoracoscopic surgery from a large nationwide reg...
  263. Reply to Migliore and Hirai
  264. Urgent lung transplantation in acute fibrinous and organizing pneumonia: a sliding door or a new perspective?
  265. Venous thromboembolism prophylaxis in thoracic surgery patients: an international survey
  266. Uniportal and three-portal video-assisted thoracic surgery lobectomy: analysis of the Italian video-assisted thoracic surgery group database
  267. Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM)
  268. Climbing the slope of the learning curve in the subxiphoid uniportal video-assisted thoracic surgery approach
  269. Endoscopic thoracic sympathectomy or sympathicotomy versus clipping in the surgical management of primary hyperhidrosis: a systematic review and meta-analysis
  270. What counts more: the patient, the surgical technique, or the hospital? A multivariable analysis of factors affecting perioperative complications of pulmonary lobectomy by video-assisted thoracoscopic surgery from a large nationwide registry
  271. Correction to: Risk factors and impact of conversion from VATS to open lobectomy: analysis from a national database
  272. Good-hearted people, Busca cardio-protected city: an evidence-based public access defibrillation project
  273. Uniportal video-assisted thoracic surgery lobectomy: a consensus report from the Uniportal VATS Interest Group (UVIG) of the European Society of Thoracic Surgeons (ESTS)
  274. Conversion due to vascular injury during video-assisted thoracic surgery lobectomy: A multicentre retrospective analysis from the Italian video-assisted thoracic surgery group registry
  275. A comparison of EGFR mutation status in tissue and plasma cell-free DNA detected by ADx-ARMS in advanced lung adenocarcinoma patients
  276. Magnetic anchoring guidance system for video-assisted thoracic surgery: the 2018 update
  277. Bioptic verification of mediastinal lymphoma relapses suspected on the basis of FDG-PET SCAN
  278. Extra-pleural pneumonectomy
  279. The relativity of operative time on the outcomes of the video-assisted thoracoscopic lobectomies
  280. Tubeless thoracic surgery: ready for prime time?
  281. Approaches to the thoracic cavities
  282. NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives
  283. History and development of minimally invasive surgery: VATS surgery
  284. Risk factors and impact of conversion from VATS to open lobectomy: analysis from a national database
  285. Geometric Considerations in Uniportal VATS
  286. Bleeding control during VATS major lung resection without conversion: safe and feasible?
  287. Is the video-assisted pulmonary segmentectomy the preferred approach to the early stage non-small cell lung cancer?
  288. Vascular injuries during VATS lobectomies: keep calm, compress and have a plan
  289. How to teach uniportal VATS to younger and elder generations: two different methods or any common overlapping points?
  290. Surgical approaches to video-assisted thoracic surgery lobectomy: a brief preface
  291. Left VATS Upper Lobectomy
  292. The “loop” technique for primary spontaneous pneumothorax: a retrospective study of 18 patients
  293. How to create a surgical database?
  294. Surgical approaches for extrapleural pneumonectomy for mesothelioma: the lower door thoracotomy
  295. Bronchoscopic management of prolonged air leak
  296. Focus on specific disease-part 2: the European Society of Thoracic Surgery chest wall database
  297. Surgical and endoscopic treatment for COPD: patients selection, techniques and results
  298. P1.14-01 Current Practices in the Management of Malignant Pericardial Effusions: A Survey Amongst Members of the European Society of Thoracic Surgeons
  299. Risk-Adjusted Costs Analysis of a Multicenter Video-Assisted Thoracoscopic Lobectomy Activity
  300. High-resolution computed tomography in the management of the first episode of primary spontaneous pneumothorax: are we sure that more is better?
  301. Systematic Review and Meta-Analysis of Endoscopic Lung Volume Reduction Using Endobronchial Valves in Severe Emphysema: Are They Better?
  302. Multicentre Validation of a Prediction Score of Prolonged Air Leak for VATS Lobectomies
  303. Virtual simulation and learning new skills in video-assisted thoracic surgery
  304. The forest of methodology and the writing of evidence-based medicine papers
  305. Non-intubated awake uniportal VATS: how to start?
  306. Fat but fit for the improved survival in lung cancer surgery
  307. Pathophysiological mechanism of post-lobectomy air leaks
  308. A project to assess the quality of the published guidelines for managing primary spontaneous pneumothorax from the Italian Society of Thoracic Surgeons
  309. Four arms robotic-assisted pulmonary resection—left upper lobectomy: how to do it
  310. The state of the art of the minimally invasive thoracic surgery in Italy
  311. Diagnostic performance of fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a meta-analysis
  312. Robotic internal mammary lymphadenectomy: another possible minimally invasive approach to sampling lymph nodes in breast cancer patients
  313. Safety of lymphadenectomy during video-assisted thoracic surgery lobectomy: analysis from a national database†
  314. Enhanced Recovery After Surgery (ERAS®) in thoracic surgical oncology
  315. 2016 Annual report from the Italian VATS Group
  316. Digital chest tomosynthesis: the 2017 updated review of an emerging application
  317. Enhanced recovery after surgery and video-assisted thoracic surgery lobectomy: the Italian VATS Group* surgical protocol
  318. Enhanced recovery after surgery protocols in video-assisted thoracic surgery lobectomies: the best is yet still to come?
  319. Lung Cancer Update 2017: from the test tube to the bed
  320. Surgical approach in oligometastatic non-small cell lung cancer
  321. The surgeon thunderbolts in 2016 lung cancer literature
  322. COUNTERPOINT: Should Segmentectomy Rather Than Lobectomy Be the Operation of Choice for Early-Stage Non-small Cell Lung Cancer? No
  323. Rebuttal From Drs Bertolaccini and Solli
  324. Robotic surgery, video-assisted thoracic surgery, and open surgery for early stage lung cancer: comparison of costs and outcomes at a single institute
  325. Uniportal non-intubated thoracic surgery
  326. The Very Experienced Time-honoUred Surgeons (VETUS) project
  327. Diaphragmatic and pericardial reconstruction after surgery for malignant pleural mesothelioma
  328. Four arms robotic-assisted pulmonary resection—right lower/middle lobectomy: how to do it
  329. National adoption of video-assisted thoracoscopic surgery (VATS) lobectomy: the Italian VATS register evaluation
  330. Surgical approaches in patients with oligometastatic non-small cell lung cancer
  331. The everlasting story of malignant pleural mesothelioma: where do we stand?
  332. Good–hearted people, Busca cardio protected city: a community of a city in the north-west of Italy involved in a public access defibrillation project
  333. Pros-cons debate about the role and evolution of uniportal video-assisted thoracic surgery (VATS)
  334. Results in video-assisted thoracic surgery for lung cancer
  335. The science behind thoracic surgery: a brief preface
  336. VATS thymectomy: oncological results and comparison between minimally invasive strategies
  337. Video-assisted thoracoscopic surgery (VATS) segmentectomy
  338. Can a standardised Ventilation Mechanical Test for quantitative intraoperative air leak grading reduce the length of hospital stay after video-assisted thoracoscopic surgery lobectomy?
  339. Cost-effectiveness analysis of sealant impact in management of moderate intraoperative alveolar air leaks during video-assisted thoracoscopic surgery lobectomy: a multicentre randomised controlled trial
  340. Thoracoscopic lobectomy for locally advanced-stage non-small cell lung cancer is a feasible and safe approach: analysis from multi-institutional national database
  341. Surgical treatment of synchronous multiple neuroendocrine lung tumours (case series): is more always better?
  342. The Geometric and Ergonomic Appeal of Uniportal Video-Assisted Thoracic Surgery
  343. Molecular analysis driven video-assisted thoracic surgery resections in bilateral synchronous lung cancers: from the test tube to the operatory room
  344. Case management: an up-to-date review of literature and a proposal of a county utilization
  345. Chondroblastoma of the rib in a 47-year-old man: a case report with a systematic review of literature
  346. Erratum to nodal management and upstaging of disease: initial results from the Italian VATS Lobectomy Registry
  347. The biostatistical minimum
  348. Uniportal video-assisted thoracoscopic surgery in hemothorax
  349. Awake non-intubated thoracic surgery: an attempt of systematic review and meta-analysis
  350. Uniportal video assisted thoracic surgery: hilar dissection
  351. Preliminary Data about Quality Check Evaluation of Italian VATS Group Database
  352. Bayesian Analysis of VATS Lobectomy Expertise in Two Thoracic Surgery Units
  353. Four arm robotic-assisted pulmonary resection-right upper lobectomy: how to do it
  354. A Risk Stratification Model for Postoperative Complications following Video-Assisted Thoracic Surgery Lobectomy
  355. Diaphragmatic flap for primary repair in thoracic esophagectomy anastomotic leak
  356. Less is more: lung-sparing direct repair of a traumatic rupture of the bronchus intermedius
  357. Uniportal video-assisted thoracic surgery for pneumothorax and blebs/bullae
  358. Standardized uptake value and radiological density attenuation as predictive and prognostic factors in patients with solitary pulmonary nodules: our experience on 1,592 patients
  359. Nodal management and upstaging of disease: initial results from the Italian VATS Lobectomy Registry
  360. Intentional Segmentectomies for Stage I Lung Cancer: An Up-to-Date Systematic Review
  361. Four arms robotic-assisted pulmonary resection—left lower lobectomy: how to do it
  362. Segmentectomy versus lobectomy for stage I non-small cell lung cancer: a systematic review and meta-analysis
  363. Video-assisted thoracoscopic surgery en bloc chest wall resection
  364. Pulmonary nodules in African migrants caused by chronic schistosomiasis
  365. Uniportal video-assisted thoracic surgery in the diagnosis of mediastinal lymphadenopathy of unknown aetiology
  366. Comparison of digital tomosynthesis and computed tomography for lung nodule detection in SOS screening program
  367. A benchmarking project on the quality of previous guidelines about the management of malignant pleural effusion from the European Society of Thoracic Surgeons (ESTS) Pleural Diseases Working Group
  368. An overview of the use of artificial neural networks in lung cancer research
  369. Pleural pressure theory revisited: a role for capillary equilibrium
  370. Subxiphoid video-assisted major lung resections: the Believers’ speech
  371. Tips and tricks of the propensity score methods in the thoracic surgery research
  372. Video-assisted thoracoscopic surgery bronchial sleeve lobectomy
  373. Technological advancements in thoracic surgery: a brief introduction to the future
  374. Video-assisted thoracic surgery for extended lung cancer disease: moving into the borderlands
  375. VATS: the age of maturity
  376. Biportal VATS approach in the treatment of penetrating thoracic trauma: a case report
  377. Magnetic anchoring guidance system in video-assisted thoracic surgery
  378. Indwelling Pleural Catheters
  379. The pulmonary nodule “discovered” by pneumonia: a case report
  380. Transthoracic needle aspiration in solitary pulmonary nodule
  381. Thoracic surgeons, mathematics, and statisticians: a new multidisciplinary team?
  382. Learning curve and established phase for uniportal VATS lobectomies: the Papworth experience
  383. Right side lobectomies
  384. Reconstructive techniques after diaphragm resection and use of the diaphragmatic flap in thoracic surgery
  385. VATS anatomic resections for lung cancer: insights from the Italian VATS Group
  386. Current practices in the management of malignant pleural effusions: a survey among members of the European Society of Thoracic Surgeons
  387. Robot-assisted lobectomy for lung cancer in the presence of intraoperatively discovered broncho-vascular anomalies affecting right upper and middle lobes
  388. Uniportal video-thoracoscopic mediastinal lymphadenectomy
  389. Surgical case description
  390. Dissection station 2 and 4 on the right hemithorax
  391. Nanos gigantium humeris insidentes: the awarded Cox proportional hazards model
  392. A bird in the hand is worth two in the bush: the choice of localization technique for non-palpable solitary pulmonary nodule
  393. Radioguided VATS resections of subcentimetric solitary pulmonary nodule/ground glass opacity:
  394. Revision of descriptors in forthcoming VIII edition of TNM classification of lung cancer: A single center validation study
  395. Enhanced recovery in thoracic surgery: A propensity-score matched cohort study
  396. Outpatient management of malignant pleural effusion in patients unfit for pleurodesis
  397. Study designs in thoracic surgery research
  398. P-197FEASIBILITY OF MAJOR LUNG RESECTIONS IN THE ELDERLY PATIENTS: A MORBIDITY RISK STRATIFICATION MODEL
  399. Bronchial reacutization and gastroesophageal reflux: is there a potential clinical correlation?
  400. Fiberoptic bronchoscopy for the detection of the gastric pepsin (Pep-test)
  401. Lymph Node Involvement in Deep Infiltrating Intestinal Endometriosis: Does It Really Mean Anything?
  402. Are the fallacies of the P value finally ended?
  403. Lymphnodal micrometastases in NSCLC: where do we stand?
  404. Open repair of pectus carinatum
  405. Management of malignant pleural effusions in patients with trapped lung with indwelling pleural catheter: how to do it
  406. Why should we prefer the single port access thoracic surgery?
  407. Geometric and ergonomic characteristics of the uniportal video-assisted thoracoscopic surgery (VATS) approach
  408. Preoperative predictive value of 18FDG CT/PET tumor metabolic parameters & SUV lymh nodes/tumor ratio in NSCLC
  409. EBUS TBNA negative lymph nodes risk stratification model: A tool for multidisciplinary team
  410. Safety and advantages of VATS biopsy in diagnosis of interstitial lung disease
  411. 165P * PREOPERATIVE POSITRON EMISSION TOMOGRAPHY FRACTAL BIOPSY OF THYMIC EPITHELIAL NEOPLASM
  412. The Importance of Being Solid or Partially Solid for a Solitary Pulmonary Nodule
  413. Spread patterns and effectiveness for surgery after ultrasound-guided rectus sheath block in adult day-case patients scheduled for umbilical hernia repair
  414. Ergon-trial: ergonomic evaluation of single-port access versus three-port access video-assisted thoracic surgery
  415. Oligometastatic Non-Small Cell Lung Cancer: The Pivotal Role of Nodal Status
  416. What is the role of lymph nodal metastases and lymphadenectomy in the surgical treatment and prognosis of thymic carcinomas and carcinoids?: Table 1:
  417. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors
  418. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the N and M Components for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors
  419. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the T component for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors
  420. To Seed or Not to Seed
  421. Analysis of spontaneous pneumothorax in the city of Cuneo: environmental correlations with meteorological and air pollutant variables
  422. Is a positron emission tomography–computed tomography scan useful in the staging of thymic epithelial neoplasms?: Table 1:
  423. 18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression
  424. Radiofrequency ablation for stage I non-small-cell lung cancer in the functionally inoperable patient
  425. 18Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography total glycolytic volume in thymic epithelial neoplasms evaluation: a reproducible image biomarker
  426. Transaxillary access to aortopulmonary window and paraaortic nodes
  427. The IASLC/ITMIG Thymic Malignancies Staging Project: Development of a Stage Classification for Thymic Malignancies
  428. Is lung cancer screening possible with digital chest tomosynthesis?
  429. Results of Li-Tho trial: a prospective randomized study on effectiveness of LigaSure(R) in lung resections
  430. Lung Cancer Detection with Digital Chest Tomosynthesis: Baseline Results from the Observational Study SOS
  431. Deep Impact of Ultrasound in the Intensive Care Unit
  432. Correlation sometimes implies causation: possible roles of correlation analysis between 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography and thymic epithelial neoplasms
  433. Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study†
  434. Home-management of malignant pleural effusion with an indwelling pleural catheter: Ten years experience
  435. Contribution of β-adrenergic receptors to exercise-induced bronchodilatation in healthy humans
  436. Deep Impact of Ultrasound in the Intensive Care Unit
  437. The relationship between meteorological variations and the onset of spontaneous pneumothorax
  438. Surgery for the treatment of the tuberculosis-destroyed lung: to protect or not to protect the bronchial stump?
  439. Not palpable? Role of radio-guided video-assisted thoracic surgery for nonpalpable solitary pulmonary nodules
  440. It sometimes happens: late tracheal rupture after total thyroidectomy
  441. Risk is not our business: safety of thoracic surgery in patients using antiplatelet therapy
  442. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms
  443. eComment: The Six Sigma approach: from mobile phones to chest tubes
  444. eComment: The evaluation of sample size: vice and virtue of statistics?
  445. eComment: About the localization techniques of solitary pulmonary nodules
  446. The standardize uptake value: light and shade of positron emission tomography
  447. ‘Six Sigma approach’ — an objective strategy in digital assessment of postoperative air leaks: a prospective randomised study
  448. Bronchial anastomosis: to wrap or not to wrap?
  449. The sound of silence: the harmonic analysis in thoracic surgery
  450. Treatment of Late Tracheomediastinal Fistula following Diagnostic Mediastinoscopy Treated by Multiple Pedicled Muscle Flaps
  451. Single-port video-assisted thoracic surgery resection: the Copernican revolution of a geometrical approach in thoracic surgery?
  452. 71PD NOT ONLY THE FINGERS: ROLE OF RADIO-GUIDED VIDEO-ASSISTED THORACIC SURGERY IN NON-PALPABLE SOLITARY PULMONARY NODULES
  453. Bronchial Carcinoid Tumours in Children — A Review
  454. A golden key can open any door of new protocol: the use of continuous digital measurement for postoperative air leak
  455. Letter to the editor
  456. Conservative management of cardiac haemangioma
  457. Lung sealant and morbidity after pleural decortication: a prospective randomized, blinded study
  458. Spontaneous Bilateral Pneumothorax in Patient With Previous Thoracoscopic Pleurodesis for Right Recurrent Pneumothorax
  459. Physiology of the Lungs in Microgravity
  460. 153PD MANAGEMENT OF MALIGNANT PLEURAL EFFUSION BY CHRONIC INDWELLING PLEURAL CATHETER
  461. Malignant Pleural Effusions: Review of Treatment and Our Experience
  462. Inguino-scrotal hernia of a double district ureter: case report and literature review
  463. P-807 Outpatient management of malignant pleural effusions
  464. New Approaches in the Management of Septic Shock